Rating: N/A

Tata India Pharma & Healthcare Fund Direct Growth



Sectoral Fund


12.053 + 0.0502

as on (03 Jul, 2020)


10.36 %

Fund Type

Open Ended

Investment Plan


Expense Ratio

1.2 %


IISL Nifty Pharma TR INR

Asset Size

235.28 Cr.

(As of 30 Apr, 2019)




The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

app screenshot
Google play store download image   Apple app store download image

Fund manager

Sailesh Jain

(since 09 Nov, 2018)

Exit load

N / A

(If redeemed within 90 days)

Minimum sip

₹ 150

minimum investment

₹ 5000

Top Holdings

This fund is been allocated in various sectors including some of the prominent ones that are widely accepted and are creating a value of trust.



Sun Pharmaceuticals Industries Ltd

13.67 %

Ipca Laboratories Ltd

10.83 %

Dr Reddy's Laboratories Ltd

10.11 %

Divi's Laboratories Ltd

6.78 %

Sector Allocation

About the Scheme Type

Sectoral Fund

As the name suggests, Sectoral Funds invest in specific sectors of the economy. These funds are less diversified as they invest entirely in a particular sector; hence, their risk factor also depends on the respective sector’s performance, this carrying high risk. For example, a FMCG fund will only invest in FMCG companies while a tech fund will invest in only tech companies.The aim of these funds is to give investors a chance to benefit from the growth prospects of a particular fund.


This fund is rated 0 stars by Morning Star Ratings.


Overview of Tata Asset Management Limited

Default for all .